BioCentury
ARTICLE | Company News

Keryx management update

January 19, 2015 8:00 AM UTC

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), New York, N.Y. Business: Endocrine/Metabolic, Renal Transitioning: Greg Madison to president and CEO from COO; he succeeds CEO Ron Bentsur ...